138 related articles for article (PubMed ID: 31306564)
21. Multiple incidence of the prescription diuretic hydrochlorothiazide in compounded nutritional supplements.
Favretto D; Visentin S; Scrivano S; Roselli E; Mattiazzi F; Pertile R; Vogliardi S; Tucci M; Montisci M
Drug Test Anal; 2019 Mar; 11(3):512-522. PubMed ID: 30194914
[TBL] [Abstract][Full Text] [Related]
22. Detection of budesonide in human urine after inhalation by liquid chromatography-mass spectrometry.
Deventer K; Mikulcíková P; Van Hoecke H; Van Eenoo P; Delbeke FT
J Pharm Biomed Anal; 2006 Oct; 42(4):474-9. PubMed ID: 16842962
[TBL] [Abstract][Full Text] [Related]
23. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls.
Sigmund G; Dib J; Tretzel L; Piper T; Bosse C; Schänzer W; Thevis M
Drug Test Anal; 2015; 7(11-12):1057-62. PubMed ID: 26481102
[TBL] [Abstract][Full Text] [Related]
24. N,N-dimethyl-2-phenylpropan-1-amine quantification in urine: application to excretion study following single oral dietary supplement dose.
Wójtowicz M; Jarek A; Chajewska K; Kwiatkowska D
Anal Bioanal Chem; 2016 Jul; 408(18):5041-7. PubMed ID: 27178556
[TBL] [Abstract][Full Text] [Related]
25. Enantioselective disposition of (R,R)-formoterol, (S,S)-formoterol and their respective glucuronides in urine following single inhaled dosing and application to doping control.
Jacobson GA; Hostrup M; Narkowicz CK; Nichols DS; Walters EH
Drug Test Anal; 2019 Jul; 11(7):950-956. PubMed ID: 30865387
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of a method to confirm the exogenous origin of prednisone and prednisolone by GC-C-IRMS.
Iannella L; Botrè F; Colamonici C; Curcio D; de la Torre X
Drug Test Anal; 2019 Nov; 11(11-12):1615-1628. PubMed ID: 31655496
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the urinary threshold concentration of formoterol in sports drug testing.
Ventura R; Damasceno LM; Ramírez R; Farré M; Bergés R; Segura J
Drug Test Anal; 2013 Apr; 5(4):266-9. PubMed ID: 23355217
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of two glucuronides resistant to enzymatic hydrolysis as markers of testosterone oral administration.
Kotronoulas A; Gomez-Gomez A; Segura J; Ventura R; Joglar J; Pozo OJ
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):212-218. PubMed ID: 27328448
[TBL] [Abstract][Full Text] [Related]
29. Distinction of inhaled and oral salbutamol by urine analysis using conventional screening procedures for doping control.
Ventura R; Segura J; Bergés R; Fitch KD; Morton AR; Berruezo S; Jiménez C
Ther Drug Monit; 2000 Jun; 22(3):277-82. PubMed ID: 10850394
[TBL] [Abstract][Full Text] [Related]
30. Detection and characterization of prednisolone metabolites in human urine by LC-MS/MS.
Matabosch X; Pozo OJ; Pérez-Mañá C; Papaseit E; Segura J; Ventura R
J Mass Spectrom; 2015 Mar; 50(3):633-42. PubMed ID: 25800201
[TBL] [Abstract][Full Text] [Related]
31. Determination of raloxifene in urine by liquid chromatography-tandem mass spectrometry for doping.
Chen TT; Huang TY; Pan RN; Chang-Chien GP; Hsu MC
J Anal Toxicol; 2013; 37(6):345-50. PubMed ID: 23772059
[TBL] [Abstract][Full Text] [Related]
32. Liquid chromatography-high resolution/ high accuracy (tandem) mass spectrometry-based identification of in vivo generated metabolites of the selective androgen receptor modulator ACP-105 for doping control purposes.
Thevis M; Thomas A; Piper T; Krug O; Delahaut P; Schänzer W
Eur J Mass Spectrom (Chichester); 2014; 20(1):73-83. PubMed ID: 24881457
[TBL] [Abstract][Full Text] [Related]
33. Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children.
Agertoft L; Pedersen S
Am J Respir Crit Care Med; 2003 Oct; 168(7):779-82. PubMed ID: 12893646
[TBL] [Abstract][Full Text] [Related]
34. Enantioselective disposition of (R)-salmeterol and (S)-salmeterol in urine following inhaled dosing and application to doping control.
Jacobson GA; Hostrup M; Narkowicz CK; Nichols DS; Haydn Walters E
Drug Test Anal; 2017 Aug; 9(8):1262-1266. PubMed ID: 28033454
[TBL] [Abstract][Full Text] [Related]
35. Urinary profile of methylprednisolone and its metabolites after oral and topical administrations.
Matabosch X; Pozo OJ; Monfort N; Pérez-Mañá C; Farré M; Marcos J; Segura J; Ventura R
J Steroid Biochem Mol Biol; 2013 Nov; 138():214-21. PubMed ID: 23792784
[TBL] [Abstract][Full Text] [Related]
36. Lomerizine, trimetazidine and bis-(4-fluorophenyl)-methylpiperazine in human urine after oral administration of lomerizine dihydrochloride: analysis by liquid chromatography-high resolution-tandem mass spectrometry.
Okano M; Sato M; Kageyama S
Drug Test Anal; 2018 Nov; 10(11-12):1689-1697. PubMed ID: 30240154
[TBL] [Abstract][Full Text] [Related]
37. Detection of urinary metabolites of arimistane in humans by gas chromatography coupled to high-accuracy mass spectrometry for antidoping analyses.
Martinez Brito D; de la Torre X; Botrè F
Rapid Commun Mass Spectrom; 2019 Dec; 33(24):1894-1905. PubMed ID: 31295379
[TBL] [Abstract][Full Text] [Related]
38. Carbon isotopic characterization of prednisolone and prednisone pharmaceutical formulations: Implications in antidoping analysis.
Iannella L; Botrè F; Colamonici C; Curcio D; Ciccarelli C; Mazzarino M; de la Torre X
Drug Test Anal; 2020 Nov; 12(11-12):1587-1598. PubMed ID: 32529794
[TBL] [Abstract][Full Text] [Related]
39. Determination of salbutamol and salbutamol glucuronide in human urine by means of liquid chromatography-tandem mass spectrometry.
Mareck U; Guddat S; Schwenke A; Beuck S; Geyer H; Flenker U; Elers J; Backer V; Thevis M; Schänzer W
Drug Test Anal; 2011; 3(11-12):820-7. PubMed ID: 22081503
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation--intersubject variability in systemic absorption from the lung.
Minto C; Li B; Tattam B; Brown K; Seale JP; Donnelly R
Br J Clin Pharmacol; 2000 Aug; 50(2):116-24. PubMed ID: 10930963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
